Plummer Nicholas 4

What Happened

• Nicholas Plummer, General Counsel — Volition Diagnostics (VolitionRx Ltd., ticker VNRX) — was granted 187,000 restricted stock units (RSUs) on Feb 26, 2026. The award was recorded as an acquisition at $0.00 (i.e., no cash paid); the filing shows an award rather than a purchase or sale.

Key Details

• Transaction date and terms: Feb 26, 2026 — 187,000 RSUs granted, acquisition price $0.00 (transaction code A).
• Vesting/earning: RSUs are earned in twelve approximately equal monthly installments beginning March 1, 2026. Once earned, they remain subject to additional time‑based vesting in a single installment on Feb 26, 2027.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnote: Award made under the Issuer’s 2024 Stock Incentive Plan in lieu of cash compensation otherwise owed; subject to continued service for each earning and vesting date. Upon vesting and settlement, Plummer will receive common shares equal to the number of RSUs earned and vested.
• Filing timeliness: Form 4 filed Feb 27, 2026 reporting the Feb 26, 2026 award; no indication of a late filing.

Context

• This was a compensation award, not an open‑market purchase or sale. RSUs convert to shares only after the specified earn and vest dates and continued service requirements are met, so this does not represent an immediate change in market exposure.
• For retail investors, awards like this primarily reflect company compensation practices rather than a direct insider bullish/bearish signal.